Linked Life Data

20467189

Source:http://linkedlifedata.com/resource/pubmed/id/20467189

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2010-9-6
pubmed:abstractText
Modified low-density lipoprotein (mLDL), mainly upon oxidative and enzymatic modification, is the major atherogenic lipoprotein. Conversely, high-density lipoprotein (HDL) is considered antiatherogenic because of its ability to remove cholesterol. The aim of this work was to analyze both the influence of HDL on the uptake of mLDL and the expression of CD36 and Fcgamma I receptors on monocytic cell lines during cell differentiation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1880-3873
pubmed:author
pubmed:issnType
Electronic
pubmed:day
31
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
844-57
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
High-density lipoprotein inhibits the uptake of modified low- density lipoprotein and the expression of CD36 and FcgammaRI.
pubmed:affiliation
Laboratório de Imunofisiopatologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil. mdias@usp.br
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't